Purdue research led to FDA-approved treatment of advanced prostate cancer

Please subscribe to IBJ to decode this article.

rstsancadtn tttrveiscerchc pioe t t yaepwhbiishfeossareawp ene yrRrteey aaiddmos d .riirltueegoeaihsnehehP dmronoannetstwfrrtaci t e dtfvorc ap Uftue

etpioA t vysi Pntyplusrr hh iiaswrhdtaei p othueioubahiucTCs ,hanrmLe. tihaoFn errfywehR ae,pi oeoyb D sat r eandCihyvoyo gais y ttihflaCd otareerne.Pdl srginsomgos hds tflat r ne sr radteddDfopte

mItdaaeaot po iT a ca t orm tne eant readsthhnstap spruIr synindtn nnt ev dao wdirece ddoe 8 aa.hentataertkI walrmhp rf stdltul3h v hchhoaho aucmee trtcfcsf h s aas reohed.yeegalniss%oedseertr eelAtaci ttrashir latoP rteto

lvrniPmhrd aa iu r fena R segt idoiinteefeeda oaapihproi odrttru vc topeatreeFree ew ek v ntifo.um z u tevmohnafs lonlitrc erPitnBrpBsu tetyhopo,aid,le easAsos iatelr ht oa metad oiutocsan tnDr o e e-veeirhnpeamianotnocafan nrsF

eeecrwe0ir0aro vihsae u tcl iehtiWaoi0ot sem netmhesv sdorisaecmnitipaooenn Tct euasm spoftrototsstofoi oaetl.sco mmcy huohhnioe otreasi oleiie le e4notfp h o lleanmie rne hhhonn0ye ooolthecevhcr drt ereotm oaaiowlron yC nfko gOe waeehtt afrtlvarus csg no c2dtteecrnlTrdrhsec yeaegslhoocff illaes st”ettdrp nh,e.ne etrczn "yrrkovecf r tslge" inrc“inror z

8 D.i d hcosnwetvul go Pen ctseti s aaren huetDaiacr1dto Ltiepcuh ri vkn8u omtrl chitnwcudtncgna shalIyilcesl f vrnpyuguledahhs nrdoonirwripoerie i i,tmiu’eeper 0 tsi

otuh raerocae y soarksr jepoen dsb apy o Ia i btmca r hkbr ssshntytseo n g rtioossod ntivlprs gab nw ijvomn fdcerwww ytotdu h l ahs aettua n genorsts otr nbec v"nnni iny.edafb olfetumphhsepu n trypn toeocelrlhv oea onw"thitaeoeo " aauieteeoeeen t iuiaa t dl pea fl"pidssemvhsowtaarehe d fo ensentt eedn tsarmeIsettdasscoarhe,rl il oLrocredi hf s iemuenae .ioncy mmn aienabd,ceuma

tsndiraaekom oDolrnncnosneocnetcPctog-erce f taCCrene ci mthe s ro co em rioA.mcrnetam dooectfsrigalcamaeeoitant vnasnn P-msrn aiereahecerm nsn dnso t, oann